Given the insecurity of certain sectors of society regarding the vaccination of children, young people and adolescents opposed to SARS-CoV-2, whether or not it is a discussion that was very important due to political tensions, is the market of the Argentine Society of Pediatrics. (SAP). ) Compare a document with a series of arguments to reaffirm that protecting older young people against COVID-19 is effective.
Thus, the organization has brought a vaccine for the little ones in the sea with Sinopharm, a vaccine approved for the organization between the ages of 3 and 11, or with Pfizer or Moderna, vaccines approved especially for other young people between 12 and 17 years old. in the face of doubts from certain parents’ organizations driven by the opposition.
As the initial SAP map points out, “vaccination has proven to be effective” in young people and young people, referring to the performance of the Chinese Sinopharm serum – which uses an inactivated virus platform – in the vaccination procedure for minors.
During their time of separation, SAP recovered that the burden of disease in young people is lower in adults, and they can also spread and transmit the virus to other people.
In addition, taking into account the “multiple social interactions” of young people in a context in which the adults responsible for them are well vaccinated, the least “appear as the organization most likely to fight infection”.
“La protección activa con vacunas seguras y eficaces permitirá también, proteger a los niños ante la emergencia de nuevas variantes, Delta o Gamma entre otras, que se están propagando más fácilmente en la población pediátrica, que al momento no está completamente vacunada”, agrega también la SAP para alimentar la necesidad de vacunación pediátrica.
Finally, he also points out that the vaccination of the greatest friends strengthens “other obviously related secondary benefits”, he says such as:
“All vaccines against Covid-19 used in our country involve inactivated viruses or viral genetic material, because the ability to galvanize immunity at the point of the mucosa does not occur with other attenuated viruses,” SAPArray specifies in its press release.
In fact, this generates a basic “epidemiological bar” that, due to society’s high vaccination policy, hinders the transmission of SARS-CoV-2. To achieve this goal, but not to be an obstacle, it is best not to protect herd immunity as much as possible.
Covid vaccination in minors: young people over 3 to 11 years of age in the country are vaccinated
Respecto a las vacunas disponibles en la Argentina, la SAP también destacó una serie de puntos que refuerzan el hecho de la seguridad y la eficacia de las vacunas:
In addition, the framework clarified the vaccination procedure for minors that has been carried out lately in the country and its past evolution: “In the Argentine Republic, in August 2021, the vaccination of young people, children and adolescents between 12 and 17 years of age began. began. with comorbidities, then continues “Vaccinating the same age group without comorbidities with messenger RNA vaccines (Moderna’s Spikevax and Pfizer’s Comirnaty) and in October 2021 the vaccination of young people aged 3 to 11 years with the Sinopharm vaccine began,” the SAP statement said.
First, you should know that young people vaccinated with the first dose will have to get their complete rest in the corresponding period while “those who have not yet started the vaccination schedule are essential for us. “
Although the pediatric society is under pressure to guarantee precisely “vigilance regarding the protection and effectiveness of the vaccines that are being used in children, young people and adolescents”, it continues with the advancement of vaccination in this age group, giving priority to young people and adolescents with chronic confinements.